Longduoduo Company Limited Reports 60.5% Revenue Decline and Net Loss in Latest 10-Q Filing

Longduoduo Company Limited reported significant financial challenges in its latest 10-Q filing for the six months ending December 31, 2025. The company generated total revenue of $1.004 million, a decrease of 60.5% compared to $2.545 million in the same period of the previous year. The decline was primarily driven by a substantial drop in commission revenue, which fell to $994,320 from $2.456 million year-over-year. Service revenue also decreased, totaling $9,709 compared to $88,916 in the prior year. The company recorded a net loss attributable to common stockholders of $349,449, compared to a profit of $406,394 in the previous year.

In terms of operational metrics, Longduoduo's total assets decreased slightly to $2.103 million from $2.126 million as of June 30, 2025. Current liabilities increased significantly to $1.121 million from $830,464, largely due to a rise in deferred revenue, which surged to $684,337 from $335,484. The company's accumulated deficit also widened to $6.519 million from $6.169 million. The total stockholders' equity attributable to common stockholders fell to $880,361 from $1.185 million, reflecting the ongoing financial losses.

Strategically, Longduoduo has been expanding its operations through acquisitions and restructuring. The company has engaged in agent sales of preventive healthcare solutions since June 2023, which has contributed to its revenue model. Additionally, the company underwent a 1-for-10 reverse stock split in September 2023, aimed at improving its stock price and market perception. The filing indicates that Longduoduo continues to focus on enhancing its healthcare service offerings through its subsidiaries, which include various health consulting firms in China.

The company reported a notable concentration of revenue, with one customer accounting for 99% of total revenue for the six months ended December 31, 2025. This heavy reliance on a single customer raises concerns about revenue stability and diversification. Furthermore, Longduoduo's cash and cash equivalents decreased to $1.543 million from $1.643 million, indicating tighter liquidity conditions. The company also reported a net cash used in operating activities of $105,572, a stark contrast to the $280,261 generated in the same period last year.

Looking ahead, Longduoduo's management has indicated a commitment to improving operational efficiency and diversifying its revenue streams. The company aims to leverage its existing network of healthcare providers to enhance service delivery and customer engagement. However, the outlook remains cautious given the current financial performance and market conditions. The company will need to address its reliance on a limited customer base and improve its profitability to ensure long-term sustainability.